Hepatoprotective Effects of Betaine Against Oxidative Stress Induced by Levodopa and Benserazide in Rats

Hepatoprotective Effects of Betaine Against Oxidative Stress Induced by Levodopa and Benserazide in Rats

Introduction: Betaine has been demonstrated to have methyl donor and antioxidant properties in our previous reports. Thus, the aim of the present study was to determine plasma homocysteine concentration and evaluate antioxidant activity of betaine following levodopa and benserazide administration, w...

Full description

Bibliographic Details
Main Authors:	M Alirezaei, K Chehari
Format:	Article
Language:	fas
Published:	Shahid Sadoughi University of Medical Sciences 2015-02-01
Series:	Majallah-i Dānishgāh-i ’Ulūm-i Pizishkī-i Shahīd Ṣadūqī Yazd
Subjects:	Benserazide Betaine Dopamine Homocysteine Levodopa Liver
Online Access:	http://jssu.ssu.ac.ir/browse.php?a_code=A-10-1819-1&slc_lang=en&sid=1

Similar Items

Betaine protects cerebellum from oxidative stress following levodopa and benserazide administration in rats
by: Masoud Alirezaei
Published: (2015-10-01)

Experience in using levodopa-benserazide
by: Elena Anatolyevna Katunina, et al.
Published: (2015-10-01)

Clinical effect of levodopa and benserazide hydrochloride tables combined with visual occlusion for amblyopia in children
by: Li-Bing Yi, et al.
Published: (2018-11-01)

Effects of rasagiline combined with levodopa and benserazide hydrochloride on motor function and homocysteine and IGF-1 levels in elderly patients with Parkinson’s disease
by: Yifan Yang, et al.
Published: (2023-10-01)

Effects of different levodopa doses on blood pressure in older patients with early and middle stages of Parkinson's disease
by: Dan Su, et al.
Published: (2023-07-01)

Benserazide-induced diarrhea – A retrospective clinical study
by: Ilona Csoti, et al.
Published: (2021-01-01)

Synthesis and Primary Activity Assay of Novel Benitrobenrazide and Benserazide Derivatives
by: Karolina Juszczak, et al.
Published: (2024-01-01)

Effect of L-DOPA/Benserazide on Propagation of Pathological α-Synuclein
by: Aki Shimozawa, et al.
Published: (2019-06-01)

Antifungal Effects and Potential Mechanisms of Benserazide Hydrochloride Alone and in Combination with Fluconazole Against Candida albicans
by: Chen X, et al.
Published: (2021-11-01)

Mythology of Parkinson’s disease: from levodopa phobia to dopamine agonist phobia
by: O. S. Levin, et al.
Published: (2020-12-01)

Health Functionalities of Betaine in Patients With Homocystinuria
by: Chelsea Truitt, et al.
Published: (2021-09-01)

Variability of plasma and urine betaine in diabetes mellitus and its relationship to methionine load test responses: an observational study
by: Lever Michael, et al.
Published: (2012-07-01)

Investigation of the Gastroprotective Effect of Betaine-Homocysteine Homeostasis on Oxidative Stress, Inflammation and Apoptosis in Ethanol-Induced Ulcer Model
by: Ayşe Çakır Gündoğdu, et al.
Published: (2022-10-01)

Evaluation of Betaine Neuroprotective Effects on 6-Hydroxydopamine-Induced hemi-Parkinsonism in Male Wistar Rats
by: Behrouz Rahmani, et al.
Published: (2019-09-01)

Mathematical insights into the effects of levodopa
by: Michael C. Reed, et al.
Published: (2012-07-01)

Effects of One-Day Application of Levodopa/Carbidopa/Entacapone versus Levodopa/Carbidopa/Opicapone in Parkinson’s Disease Patients
by: Thomas Müller, et al.
Published: (2022-04-01)

Levodopa acts centrally to induce an antinociceptive action against colonic distension through activation of D2 dopamine receptors and the orexinergic system in the brain in conscious rats
by: Toshikatsu Okumura, et al.
Published: (2016-02-01)

A homozygous PRKN-associated juvenile Parkinson's disease with pregnancy in China
by: Hong-xing Li, et al.
Published: (2023-02-01)

Benserazide, a dopadecarboxylase inhibitor, suppresses tumor growth by targeting hexokinase 2
by: Wei Li, et al.
Published: (2017-04-01)

What mechanisms are responsible for the reuptake of levodopa-derived dopamine in parkinsonian striatum?
by: Haruo Nishijima, et al.
Published: (2016-12-01)

Antioxidant effects of betaine against Indomethacin-induced gastric damage in rats
by: M Alirezaei, et al.
Published: (2016-10-01)

Electrochemical Sensor Based on Multi-Walled Carbon Nanotubes and N-Doped TiO<sub>2</sub> Nanoparticles for Voltametric Simultaneous Determination of Benserazide and Levodopa
by: Elisangela Pacheco da Silva, et al.
Published: (2022-12-01)

Dystonia and levodopa-induced dyskinesias in Parkinson's disease: Is there a connection?
by: Paolo Calabresi, et al.
Published: (2019-12-01)

The cross-hemispheric nigrostriatal pathway prevents the expression of levodopa-induced dyskinesias
by: Vishakh Iyer, et al.
Published: (2021-11-01)

Levodopa enhances reward learning but impairs reversal learning in Parkinson’s disease patients
by: Ahmed A. Moustafa
Published: (2011-01-01)

The Effect of 3-Week Betaine Supplementation on Blood Biomarkers of Cardiometabolic Health in Young Physically Active Males
by: Emilia Zawieja, et al.
Published: (2022-08-01)

Role of autophagy in betaine-promoted hepatoprotection against non-alcoholic fatty liver disease in mice
by: Jinuk Seo, et al.
Published: (2024-01-01)

Betaine alleviates cognitive impairment induced by homocysteine through attenuating NLRP3-mediated microglial pyroptosis in an m6A-YTHDF2-dependent manner
by: Zhi-Jun Yang, et al.
Published: (2024-02-01)

Effect of Levodopa on Reward and Impulsivity in a Rat Model of Parkinson’s Disease
by: Miguel M. Carvalho, et al.
Published: (2017-08-01)

Continuous long-range measurement of tonic dopamine with advanced FSCV for pharmacodynamic analysis of levodopa-induced dyskinesia in Parkinson’s disease
by: Jeongrak Park, et al.
Published: (2024-01-01)

Efeito da levodopa na mecânica coclear e no sistema auditivo eferente de indivíduos com doença de Parkinson
by: Marcia da Silva Lopes, et al.
Published: (2019-02-01)

Evaluating the Effectiveness of Betaine Against Oxidative and Histopathological Damage Caused by Acrylamide in the Rat Brain
by: Javad Fasahi, et al.
Published: (2023-10-01)

Levodopa-Induced Dyskinesia in Parkinson’s Disease: Pathogenesis and Emerging Treatment Strategies
by: Destany K. Kwon, et al.
Published: (2022-11-01)

Protective effects of betaine-homocysteine methyl transferase on oxidative damaged human lens epithelial cells induced by high homocysteine
by: Hai-Yan Zhou, et al.
Published: (2019-10-01)

Relationship Between Plasma Homocystein Levels and Polyneuropaty in Patients Using Levodopa For Idiopathic Parkinson’s Disease
by: Mithat Bedir, et al.
Published: (2012-06-01)

Surviving environmental stress: the role of betaine aldehyde dehydrogenase in marine crustaceans
by: NA Stephens-Camacho, et al.
Published: (2015-02-01)

Human Serum Betaine and Associated Biomarker Concentrations Following a 14 Day Supplemental Betaine Loading Protocol and during a 28 Day Washout Period: A Pilot Investigation
by: Steven B. Machek, et al.
Published: (2022-01-01)

Efficacy and pharmacokinetics of betaine in CBS and cblC deficiencies: a cross-over randomized controlled trial
by: Apolline Imbard, et al.
Published: (2022-11-01)

High Betaine and Dynamic Increase of Betaine Levels Are Both Associated With Poor Prognosis of Patients With Pulmonary Hypertension
by: Yicheng Yang, et al.
Published: (2022-03-01)

Antifungal Mechanism of Action of Lauryl Betaine Against Skin-Associated Fungus Malassezia restricta
by: Eunsoo Do, et al.
Published: (2019-06-01)